EUROPEAN PRODUCT & INNOVATION PLATFORM

Sikalias EU

European product platform for Sikalias L-Cystine 500 mg and selected healthy-ageing development concepts.

500 mgL-Cystine per vegetarian capsule
30capsules
60capsules
90capsules
Commercial product

Sikalias L-Cystine 500 mg

A vegetarian-capsule food supplement available in three presentations. Purchase availability and current retail terms are managed through Sikalias Pharmacy in Greece.

Development concepts

Healthy ageing and longevity

Two public concept summaries are presented to support formulation, development and distribution dialogue. They are not currently offered for sale and do not constitute approved health claims.

From concept to compliant market pathway

Sikalias.eu is the commercial-facing layer. Scientific concepts are developed with the Laboratories, public scientific rationale is connected to the knowledge ecosystem, and purchase in Greece is routed through the licensed pharmacy channel.

  • Scientific rationale and formula architecture
  • Supplier and raw-material qualification
  • Stability and manufacturing feasibility
  • EU claims and regulatory review
  • Distribution and pharmacy purchase route